Fuse Biotherapeutics

Manufacturing · California, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

6080 Center Dr Fl 6, Los Angeles, Califo...

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
4
1
1
1
1

About Fuse Biotherapeutics

Founded in 2021, Fuse Biotherapeutics is a biotech company with a focus on cancer treatments with heardquarters in Los Angeles, California.Explore more
Fuse Biotherapeutics's Social MediaPopular SearchesFuse Biotherapeutics IncFuse BiotherapeuticsSIC Code 28,283NAICS Code 32,325Show more

Fuse Biotherapeutics Org Chart

PhoneEmail
BR
United States flag for contact location.

Chief Scientific Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Fuse Biotherapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Fuse Biotherapeutics

Compare insights from companies similar to Fuse Biotherapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Fuse Biotherapeutics

<$5M
1-10
Private
$9.5M
2021
BR
Brian RabinovichChief Scientific Officer
<$5M
11-50
Private
$100M
2021
Terrence Connolly, President & Chief Executive Officer at K36 Therapeutics
Terrence ConnollyPresident & CEO
<$5M
1-10
Private
-
2012
N/A
<$5M
1-10
Private
-
-
N/A
<$5M
1-10
Private
-
2021
RC
Rob ColemanMedical Advisor
11-50
Public
$15M
2020
SS
Shay ShemeshExecutive Vice President & Development Chief & Operations Officer
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Fuse Biotherapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Fuse Biotherapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Fuse Biotherapeutics.

Fuse Biotherapeutics financials insights

Gather financial insights about Fuse Biotherapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2021

Angel/Seed

$9.5M

See All Fuse Biotherapeutics's Financials Insights

Fuse Biotherapeutics Tech Stack

A closer look at the technologies used by Fuse Biotherapeutics

Fuse Biotherapeutics News & Media

  • FuseBio Presents New Data at AACR: Targeting a Functionally-Selective IL-18 (F-18) to PD-1: A Next Generation Checkpoint Inhibitor with Enhanced Anti-Tumor Activity

    FuseBio's unique attenuation mechanism renders IL-18, a functionally selective IL-18, resistant to IL-18BP and 1 million percent less active in circulation and yet still retain nearly full activity when targeted to PD-1+/IL-18R+ cells, the key functional immune cells in tumors. It is designed to retain full activity of PD-1 checkpoint blockade and simultaneously deliver a functionally selective IL-18 (F-18) to preserve [PR.com]
  • Latest Updates of 9 Viva's Portfolio Companies

    HONG KONG, June 2, 2023 /PRNewswire/ -- Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies' long-term development. This continuous innovation keeps companies up to date and promotes the evolution of R&D and the success of commercialization. Recently, 9 of Viva's portfolio companies have achieved significant results and progress. Keep reading for more details. Triumvira to Present Phase I/II Data of TAC01-HER2 in Cl
  • Latest Updates of 9 Viva's Portfolio Companies

    HONG KONG, June 2, 2023 /PRNewswire/ -- Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies' long-term development. This continuous innovation keeps companies up to date and promotes the evolution of R&D and...
  • Fuse Biotherapeutics Raises $9.5M in Sees Funding

    Fuse Biotherapeutics, a Los Angeles CA-based company developing an immune modulating therapeutics that directs and potentiates both innate and adaptive immunity, raised $9.5M in Seed funding. The round was led by Viva BioInnovato with participation from Sherpa Healthcare Partners, Ivy Venture Group, Sirona Capital and GC&H Investments. The company intends to use the funds for […] The post Fuse Biotherapeutics Raises $9.5M in Sees Funding appeared first on FinSMEs.
Read more news

Top Manufacturing Companies

Frequently Asked Questions Regarding Fuse Biotherapeutics

What is Fuse Biotherapeutics's official website?
Fuse Biotherapeutics's official website is www.fusebiotx.com
What is Fuse Biotherapeutics's Revenue?
Fuse Biotherapeutics's revenue is <$5 Million
What is Fuse Biotherapeutics's SIC code?
Fuse Biotherapeutics's SIC: 28,283
What is Fuse Biotherapeutics's NAICS code?
Fuse Biotherapeutics's NAICS: 32,325
How many employees does Fuse Biotherapeutics have?
Fuse Biotherapeutics has 1-10 employees
What industry does Fuse Biotherapeutics belong to?
Fuse Biotherapeutics is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Fuse Biotherapeutics competition?
Fuse Biotherapeutics top competitors include: Nuvectis Pharma, My Non-hodgkin Lymphoma, K36 Therapeutics, A28 Therapeutics
What technology does Fuse Biotherapeutics use?
Some of the popular technologies that Fuse Biotherapeutics uses are: Sentry, Microsoft 365, F5 BIG-IP Platform, GoDaddy DNS
What does Fuse Biotherapeutics do?

Founded in 2021, Fuse Biotherapeutics is a biotech company with a focus on cancer treatments with heardquarters in Los Angeles, California.... Read More

What are Fuse Biotherapeutics social media links?
Fuse Biotherapeutics Linkedin page Fuse Biotherapeutics Twitter page
Who invested in Fuse Biotherapeutics?
Fuse Biotherapeutics has 5 investors including Ivy Venture Group, Viva BioInnovator, GC&H Investments and Sherpa Healthcare Partners.
Is Fuse Biotherapeutics a public company?
Fuse Biotherapeutics is private company therefore does not currently have an official ticker symbol
See more information about Fuse Biotherapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.